Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00732732
Other study ID # HAC 08-01-165
Secondary ID
Status Terminated
Phase N/A
First received August 8, 2008
Last updated August 5, 2011
Start date September 2008
Est. completion date January 2010

Study information

Verified date August 2011
Source Georgia Regents University
Contact n/a
Is FDA regulated No
Health authority India: Institutional Review BoardUnited States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Green banana has been traditionally used in diarrheal and other diseases. Recent studies have shown that green banana is beneficial in children with diarrhea.

The purpose of this study is to try green banana in a portable, storable and dosable form in infants with diarrhea.

Infants with diarrhea and meeting the inclusion criteria will receive either green banana powder or placebo (microcrystalline cellulose). Their response will be monitored for 10 days. The subjects, parents and researchers conducting the study will not know whether banana powder or placebo is being given to that particular subject (double blind randomized study).

Two hundred patients will be enrolled in 24 months.


Recruitment information / eligibility

Status Terminated
Enrollment 200
Est. completion date January 2010
Est. primary completion date January 2010
Accepts healthy volunteers No
Gender Both
Age group 5 Months to 24 Months
Eligibility Inclusion Criteria:

1. Children between the ages of 5 months and 2 years of age admitted in the inpatient pediatric ward of Bhatpara Sub divisional Hospital.

2. Infants with more than 3 stools/day which is more frequent than the usual bowel habit of the study subject

3. The consistency of the stool is such that it takes the shape of the container into which it is put in.

4. Duration of symptoms should be less than 14 days.

Exclusion Criteria:

1. Children with bloody diarrhea

2. Children with lethargy, fever or other signs of septicemia

3. Children with shock.

4. Children unable to take medications orally.

5. Children with impaired consciousness.

6. Children whose parents refuse permission to be included in the study.

7. Children who are not usual residents of the area and will not be available for follow up.

8. Children with chronic illnesses such as congenital heart disease, renal failure, chronic liver disease, chronic lung disease, inflammatory bowel disease, immune deficiency etc.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Green banana powder
Green banana in powder form, 10 grams/ day for children below 10 kg, 20 grams for those weighing 10 Kg or more. Protocol Modified on Aug 5th 2009 to give 20 grams irrespective of age.
Other:
Microcrystalline cellulose
Microcrystalline cellulose 10 gm/ day for subjects below 10 kg in weight, 20 gms/ day for those weighing 10 Kg or more

Locations

Country Name City State
India Bhatpara Subdivisional Hospital Bhatpara West Bengal

Sponsors (3)

Lead Sponsor Collaborator
Georgia Regents University NRS Medical College, Kolkata, West Bengal, India, School of Tropical Medicine, Kolkata, West Bengal, India

Country where clinical trial is conducted

India, 

References & Publications (2)

Rabbani GH, Teka T, Saha SK, Zaman B, Majid N, Khatun M, Wahed MA, Fuchs GJ. Green banana and pectin improve small intestinal permeability and reduce fluid loss in Bangladeshi children with persistent diarrhea. Dig Dis Sci. 2004 Mar;49(3):475-84. — View Citation

Rabbani GH, Teka T, Zaman B, Majid N, Khatun M, Fuchs GJ. Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladeshi children. Gastroenterology. 2001 Sep;121(3):554-60. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of stools per day. Daily for 10 days No
Secondary Change in the consistency of stool. Daily for 10 days No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03598010 - Safety, Tolerability and Preliminary Efficacy of Lenodiar Pediatric in Diarrhea N/A
Recruiting NCT04654832 - IVC Index in Patient With Diarrhea and Dehydration And How It Affects Its Management
Completed NCT04061538 - Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age N/A
Completed NCT05322655 - PAthogen Transmission and Health Outcome Models of Enteric Disease
Recruiting NCT02870751 - Human Challenge Model With ST-only Enterotoxigenic Escherichia Coli Phase 1
Completed NCT01345695 - Bihar Evaluation of Social Franchising and Telemedicine N/A
Recruiting NCT04528303 - Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty N/A
Completed NCT04335877 - Effect of Prompting the Supply of Zinc/LO-ORS Co-packs in the Private Sector Plus BCI on Childhood Diarrhea Treatment N/A
Active, not recruiting NCT03012048 - Effectiveness of Point-of-use Water Treatment Technologies to Prevent Stunting Among Children in South Africa N/A
Completed NCT04677296 - Efficacy and Safety of "VS002A" With the Standard WHO-ORS in Non-cholera Acute Watery Diarrhea in Infants and Young Children N/A
Completed NCT04209751 - Descriptive Study of Pathogens Involved in Summer Diarrhea in Children Leading to Pediatric Emergency Room Visits (PE-DIA)
Completed NCT00447161 - Preventing Antibiotic-Associated DiarRhea Using Erceflora Phase 4
Recruiting NCT05766826 - Coupons for Safe Water Project N/A
Terminated NCT04628819 - Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea in Children N/A
Completed NCT03473561 - Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea Phase 3